Selank Research Video Explainer

For in-vitro and laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.

This short video explains Selank as a research compound. Selank is Tuftsin-PGP Heptapeptide Studied in GABAergic & Enkephalin Modulation. It covers its molecular identity (CAS 129954-34-3, 751.89 g/mol) and the pathways studied in laboratory models. A second video is included below.

In stock and UK lab tested

Key facts

What Selank is studied for

• Investigating allosteric modulation of GABA-A receptors without sedative benzodiazepine binding.
• Studying inhibition of plasma and central enkephalin-degrading metallopeptidases.
• Examining neuro-immune cross-talk, IL-6 cytokine balance and hippocampal BDNF expression.

What the video covers

Each slide in the 60-second explainer follows one line of published laboratory work, not a medical outcome.

• 1. GABA-A Allosteric Modulation Shifts GABA-A receptor affinity for endogenous GABA, modulating chloride ion channel flux.
• 2. Enkephalinase Inhibition Preserves endogenous Leu- and Met-enkephalin half-life by inhibiting degrading peptidases.
• 3. Neuro-Immune Gene Regulation Studied for monoamine turnover (5-HT, dopamine) and cytokine transcription in cell models.

Related research videos

• Semax research video
• PT-141 (Bremelanotide) research video
• Semax + Selank Blend (20 mg) research video
• All 164 peptide research videos

Batch checks and handling

Every vial carries a report number. Match it to its certificate on the COA verification page before you start work. Lyophilised vials are best kept sealed, dry and at −20 °C or colder, away from light. Reconstitution and storage are covered step by step in our reconstitution and storage guide.

Corex Vitality™ supplies Selank strictly for in-vitro laboratory research by adults aged 18 or over. It is not a medicine, it is not for human or veterinary use, and no information on this page describes use in people or animals. Read the full terms of sale.